<DOC>
	<DOCNO>NCT02576587</DOCNO>
	<brief_summary>The Elucidation Influence Sleep Apnea Risk Atrial Fibrillation study . The study involve case control design investigate extent independent relationship sleep disorder breathing ( SDB ) paroxysmal atrial fibrillation ( PAF ) . Cases define clinically identify patient PAF control without AF . In order rigorously address important biologic confounding influence , case control individually match base upon age , gender , race , body mass index . Those participant PAF SDB ( Apnea Hypopnea Index , AHI &gt; =15 ) ask return follow exam 3 month SDB treatment Clinical Research Unit ( CRU ) collection measure collect baseline exam observe significant change purpose collect effect size data inform future clinical trial . The total duration study 4 year . The duration individual participant one 13 week month , include 3-month treatment period moderate severe SDB , i.e . AHI &gt; 15 .</brief_summary>
	<brief_title>Influence Sleep Apnea Risk Atrial Fibrillation</brief_title>
	<detailed_description>Sleep-disordered breathing ( SDB ) common patient cardiovascular disease attendant hypoxemia autonomic dysfunction create milieu likely enhance AF propensity . Thus , SDB may represent novel target AF prevention treatment strategy . Although prior cross-sectional work show 2-4 fold high odds AF relate SDB , report include cardiac structural data autonomic/biochemical measure , address arrhythmic event occur overnight sleep study . In proposal , examine paroxysmal AF ( PAF ) , early stage risk factor persistent AF , relevant proposal occur prior extensive cardiac electrical remodeling/fibrosis . OUTLINE OF STUDY VISITS Baseline Visit ( SA 1 2 ) . After informed consent , eligible participant schedule arrive overnight visit CRU . During evening , participant undergo questionnaire administration , blood pressure measurement , anthropometry . They provide dinner undergo polysomnography ( PSG ) . In morning , participant undergo fasting venipuncture , overnight urine collection , ECHO , 6 minute walk test , vascular measure blood pressure measurement . For PAF ( case ) , hook-up continuous ECG monitoring perform along education regard handle device bath instruction , etc . All measurement DCRU/CRU perform blind PAF status . The unblinded staff dedicate research assistant perform ECG monitoring hook-up . Blinded staff collect process data perform data entry . After baseline visit , participant PAF ( n=150 ) undergo hook-up ECG monitor activity monitor baseline visit wear 7-21 day period . Follow-Up Visit ( SA3 ) . Those SDB ( AHI &gt; =15 ) without evidence central apnea ( central apnea index &gt; 5 ) Cheyne Stokes Respirations via baseline visit PSG PAF undergo follow . A 5-7 day home-based auto-titration ( APAP , Respironics Autopap System One humidifier ) identify optimal positive airway pressure ( PAP ) setting perform ( settings 4-20cm H2O ) . At end 5-7 day titration , goal identify pressure result AHI &lt; 5 events/hour ( optimally ) . The research assistant re-set device deliver optimal fix pressure identify PI secure wireless web-site . An overnight DCRUCRU visit schedule 3 month wear CPAP measure perform baseline visit collect . STUDY PROCEDURES 2-DIMENSIONAL DOPPLER ECHOCARDIOGRAPHY . Parasternal , apical subcostal 2-D view apical 3D view obtain transducer orientation gain setting adjust optimally define endocardial surface cardiac chamber . POLYSOMNOGRAPHY ( PSG ) . Procedure PSG : Research PSG perform use Compumedics E-series system ( Abbottsford , AU ) include 3 cortical encephalogram , bilateral electro-oculograms , bipolar submental electromyogram , thoracic abdominal respiratory inductance plethysmography , airflow ( nasal-oral thermocouple nasal cannula pressure record ) , oximetry ( use highly sensitive finger pulse oximeter , sample frequency 25Hz ) , electrocardiogram ( ECG ) 250Hz ( use derive HRV measure autonomic function ) ; body position ( mercury switch sensor ) , bilateral leg movement . EEGs record 125Hz . 3 ) 7-21 Day CONTINUOUS ECG MONITORING . Procedure : A 3-lead ( 2 channel ) , wireless , lightweight ECG monitoring device use collect ECG data 7-21 day period PAF baseline follow-up CRU visit . ACTIVITY MONITORING . Procedure : An accelerometer ( GT3X+ , Actigraph Co. , Ft Walton Bch , Fl ) use 7-21 day , coincident time continuous ECG monitoring . FASTING VENIPUNCTURE ( 52cc ) . Procedure : Phlebotomy perform morning baseline follow-up visit use standard technique train research staff follow write procedure . 6 ) DNA collection . Blood collect extract RNA , store test future hypotheses regard genetic determinant treatment response . OVERNIGHT URINE . Procedure : Overnight urine collection perform . ANTHROPOMETRY . Height ( inch , cm ) , neck circumference ( cm ) , waist circumference ( cm ) , hip circumference ( cm ) obtain . Skinfolds measure calibrate metal caliper 7 site ( chest , calf , thigh , calf , subscapular , midaxillary , suprailiac , abdominal ) . RESTING BLOOD PRESSURE ( BP ) . BP measure participant sit quietly least 5 minute follow standardized guideline use calibrated sphygmomanometer . Measurements repeat three time record . QUESTIONNAIRES . The following collected : ) The Berlin Sleep Questionnaire , b ) Epworth Sleepiness Scale , c ) The Sleep Habits Medical Condition Questionnaire ) The Medical Outcomes Survey-SF 36 ( MOS-SF ) e ) Patient Health Questionnaire-9 ( PHQ-9 ) f ) Daily ECG/Activity Log g ) Atrial Fibrillation Effect Quality-of-life , 20-item questionnaire ass impact atrial fibrillation quality life . 6 Minute Walk Test . Baseline oxygen saturation heart rate record . If oxygen saturation &gt; 90 % , proceed protocol . Using BORG Scale record rate symptom breathlessness leg fatigue 6 minute walk usual pace . Arterial Applanation Tonometry : Radial artery measurement perform sphygmomanometric pressure obtain use applanation tonometry probe minimum two consecutive measurement obtain pulse wave analysis result . For pulse wave velocity , lead II ECG perform along cardotid femoral applanation tomometry .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Inclusion Criteria Cases : PAF define recurrent episode AF , selfterminate within 7day period ( base upon AHA consensus statement 77 ) Age 1880 year Individuals able participate &gt; 2 overnight/daytime sleep physiologic assessment 3 month period . Inclusion Criteria Controls : Age 18 80 year Individuals normal sinus rhythm ( NSR ) current AF history AF Individuals able participate overnight/daytime sleep physiologic assessment . Exclusion Criteria Cases : PAF rapid uncontrolled rate ( &gt; 120bpm ) Postoperative PAF History cardiac ablation successful electrocardioversion PAF ( ablation arrhythmias AVNRT PAF persist cardioversion acceptable ) Valvular stenosis , prosthesis significant valvular insufficiency [ i.e . moderate great severity aortic stenosis ( aortic valve area &lt; 1.5 cm2 ) , mitral regurgitation moderate severe degree ( &gt; 20 % regurgitant fraction ) moderate great severity mitral stenosis ( mitral valve area &lt; 1.5 cm2 ) ] Atrial septal defect Infiltrative/restrictive cardiomyopathy Sick sinus syndrome Previously diagnose SDB specific SDB treatment ( CPAP , oral appliance ) Severe chronic insomnia Circadian rhythm disorder ( e.g . shift work sleep disorder , delay advanced sleep phase syndrome ) Insufficient sleep syndrome define report sleep duration &lt; 4 hr Supplemental oxygen use Unstable medical condition ( e.g. , new onset change angina , myocardial infarction congestive heart failure exacerbation document within previous 3 month , systolic heart failure ( Left Ventricular Ejection Fraction &lt; 35 % ) , high grade cardiac dysrhythmia/heart block , stroke functional limitation , uncontrolled hypertension ( BP &gt; 170/110 ) , abdominal aneurysm &gt; 5.5 cm &gt; 1 cm growth/year , uncontrolled diabetes mellitus ( HbA1c &gt; 9.0 ) , pulmonary hypertension , nonskin cancer diagnosis treatment within previous year , end stage renal hepatic failure , immunodeficiency ( HIV , HCV ) , uncontrolled hypo hyperthyroidism ) Psychiatric disorder inadequately treat Compromised competence Alcohol abuse ( currently drink &gt; 5 alcoholic drinks/day ) Pregnancy Inability provide inform consent Illicit drug use last 6 month Rate control antiarrhythmic medication ( Classes IIII V ) clinical occurrence PAF Has Pacemaker Implantable cardioverterdefibrillator . Rationale criterion : The goal study include patient PAF secondary postoperative period valvular disease without ablation process would result alteration atrial physiology preclude assessment independent SDB effect AF independent condition . Patients sleep disorder exclude sleep disorder may influence arrhythmogenesis . Those treatment SDB exclude treatment would preclude assessment SDB pathophysiologic effect atrial arrhythmogenesis . Those unstable medical condition rapid uncontrolled heart rate exclude due safety reason . Note : Exclusion criterion positive airway pressure ( PAP ) intervention : Central Apnea Index &gt; 5 noted baseline examination sleep study evidence Cheyne Stokes Respirations/periodic breathing ( cyclical crescendo decrescendo change breathe amplitude ) . Exclusion Criteria Controls : Current history AF , otherwise exclusion criterion list case .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>